Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1911studies shown
Showing 1-12 of 1,911
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Argentina, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolarity type I With Current Mania

This study is looking at care and outcomes for people with Bipolarity I or Mania. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Bipolarity
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951711

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Croatia, India, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06462586

Lumateperone in the Acute Treatment of people with Bipolar Mania

This observational study is following people with bipolarity, Manic to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
Drug study icon
RecruitingNCT06462612

Lumateperone in the Treatment of people with Bipolar Mania

This observational study is following people with bipolarity, Manic to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Romania, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
Drug study icon
RecruitingNCT07046494

RAP-219 for Bipolarity

This study is recruiting in the United States. It is testing RAP-219 for Bipolarity.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Rapport Therapeutics Inc.
Condition
Bipolarity
Drug study icon
RecruitingNCT06696755

Adverse Events and Change for Bipolarity

This study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity
Device study icon
RecruitingNCT07194278

Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolarity

This study is looking at whether a digital support tool can help people with Bipolarity type I. Participants receive a study treatment and complete follow-up visits and assessments.

In Paris
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Bipolarity
Behavioral study icon
RecruitingNCT05427123

Children's Bipolar Network Treatment study I

This observational study is following people with bipolarity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 9 Years to 19 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Bipolarity
Drug study icon
RecruitingNCT07286175

Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for Bipolarity.

Multiple locations, including Orange
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.